<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641665</url>
  </required_header>
  <id_info>
    <org_study_id>2016001</org_study_id>
    <nct_id>NCT02641665</nct_id>
  </id_info>
  <brief_title>Plasma Biomarkers in Cardiac Valve Surgery</brief_title>
  <official_title>Measurement of Four Plasma Biomarkers for Risk Stratification and Determination of Functional Recovery After Cardiac Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The level of four biomarkers will be measured in the patients' plasma after induction of
      anaesthesia. There biomarkers are NT-ProBNP, ST2, Galectin-3 and GDF-15. The level of these
      marker will then be correlated with early (30 days) and late (one year) patients' prognosis
      and with functional recovery (MLHFQ score).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite primary outcome</measure>
    <time_frame>30 days</time_frame>
    <description>In hospital or 30-days mortality or inotropic support during more than 48 hours or lengthy of ICU stay longer than 5 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU readmission</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative AKI</measure>
    <time_frame>48 hours</time_frame>
    <description>AKIN stage during the first 48 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ejection fraction</measure>
    <time_frame>1 year</time_frame>
    <description>EF at 30 days and at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA</measure>
    <time_frame>1 year</time_frame>
    <description>NYHA class at 30 days and at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MLHFQ</measure>
    <time_frame>1 year</time_frame>
    <description>Minnesota living with heart failure questionnaire at 30 days and at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reshopitalisation</measure>
    <time_frame>1 year</time_frame>
    <description>hospital admission for cardiac failure during the first postoperative year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>one year mortality</measure>
    <time_frame>1 year</time_frame>
    <description>mortality during the first postoperative year.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Elective Valvular Cardiac Surgery</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac valve surgery</intervention_name>
    <description>Aortic or mitral valve replacement/repair performed in isolation of in addition to coronary artery bypass graft(s).</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Arterial blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing elective or urgent cardiac valve surgery in isolation of in
        combination with CABG.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Elective/urgent aortic or mitral valve surgery in isolation or combined with CABG

        Exclusion Criteria:

          -  Emergency or salvage surgery

          -  Inability to consent

          -  Previous cardiac surgery

          -  Stage IV or V CDK (GFR ≤ 30 ml/min) or dialysis

          -  Active Endocarditis

          -  Liver cirrhosis

          -  Chronic atrial fibrillation

          -  Pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gregory A Hans, MD, PhD</last_name>
    <phone>+3243667655</phone>
    <email>G.Hans@chu.ulg.ac.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU of Liege</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory A Hans, MD, PhD</last_name>
      <phone>+3243667655</phone>
      <email>G.Hans@chu.ulg.ac.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2015</study_first_submitted>
  <study_first_submitted_qc>December 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>October 5, 2017</last_update_submitted>
  <last_update_submitted_qc>October 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Jean François Brichant</investigator_full_name>
    <investigator_title>Professor, Head of Department</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

